Gabriel Cara Fuentes
banner
carafuentes-neph.bsky.social
Gabriel Cara Fuentes
@carafuentes-neph.bsky.social
Peds Nephrologist at Nationwide Children's Hospital. Trying to redefine idiopathic nephrotic syndrome and discover new therapies
Reposted by Gabriel Cara Fuentes
Registration remains open for the 15th Annual Glomerular Disease 2026 Conference on Friday, February 6th, 2026. Feel free to register for our virtual conference using the following link: www.eventleaf.com/At...
November 20, 2025 at 6:17 PM
Reposted by Gabriel Cara Fuentes
The UofL contingent proteomics crew spanning 25 yrs and all kinds of areas of mass spectrometry. Staff Excellence Awards!
November 18, 2025 at 10:05 PM
Reposted by Gabriel Cara Fuentes
From RAAS blockade to regenerative medicine: evolving treatment strategies in #Alport syndrome pubmed.ncbi.nlm.nih.gov/41243004/
November 17, 2025 at 3:54 PM
Reposted by Gabriel Cara Fuentes
Another simultaneous publication from the afternoon session

Albuminuria as an acceptable surrogate outcome (per our discussion earlier today)

www.nature.com/articles/s41... in @naturemedicine.bsky.social @nature.com sadly paywalled

#KidneyWk
A meta-analysis of albuminuria as a surrogate endpoint for kidney failure - Nature Medicine
In a meta-analysis of 48 randomized trials of chronic kidney disease progression, reduction in the 6-month urinary albumin:creatinine ratio was associated with lower hazard ratios of established kidne...
www.nature.com
November 6, 2025 at 10:49 PM
Reposted by Gabriel Cara Fuentes
📢 New Glomerular Diseases Guideline out now!

🧒 Up-to-date recommendations on diagnosing & treating immune-mediated #GlomerularDisease in children.
💊 Guidance on immunosuppression & supportive care.
✅ Endorsed by @BAPNnephrology

📃: ow.ly/HtZL50XnTCL

#KidneyDisease
November 11, 2025 at 8:10 AM
Reposted by Gabriel Cara Fuentes
Previously shared: Systemic shock can lead to vascular dysfunction and organ failure.

This issue’s cover features work by Alejandro P. Adam @aleadam.bsky.social showing inflammatory cytokines drives endothelial stress via cytoplasmic DNA.

www.jci.org/articles/vie...
November 9, 2025 at 2:01 PM
Reposted by Gabriel Cara Fuentes
This is not an acceptable status quo.

Children with kidney disease are being left behind.

#KidneyWk
November 8, 2025 at 8:28 PM
Reposted by Gabriel Cara Fuentes
The big kidney meeting is this week in Houston, Texas. I will be there postering about mass spectrometry and kidney disease and 3 other collaborators from our Kidney and Proteomics Technology Center out of UofL.
November 3, 2025 at 1:07 PM
Reposted by Gabriel Cara Fuentes
Pediatric nephrology is currently facing a shortage of physicians and unfilled fellowship positions. In this month's #ASNKidneyNews, one resident shares their perspective. kidney.pub/KN1710-05
October 17, 2025 at 4:00 PM
Reposted by Gabriel Cara Fuentes
Finally, someone has solved a real problem with AI! No more having to take a paper in the format for a journal that rejected you, and reformat it for a new journal. Well done!! formatmypaper.com
October 15, 2025 at 6:33 AM
Reposted by Gabriel Cara Fuentes
APRIL is key 🔑 in the development of Antibody-secreting B lymphocytes ca. 2018 from @JASN_News
#IgAN #Nephpearls #RKDSummit #NephSky

👉 pubmed.ncbi.nlm.nih.gov/29326157/
October 11, 2025 at 6:11 PM
Reposted by Gabriel Cara Fuentes
Dr. Liz Kiernan talks us through "Endothelium in Kidney Health and Disease," by reviewing #kidney vasculature #physiology and eGFR, structure and function of #endothelium, #pathophysiology and signaling, #biomarkers and #therapeutics. @uwmedicine.bsky.social #nephsky

Watch: youtu.be/b1Nr0QRcVeQ
Elizabeth Kiernan, MD - Endothelium in Kidney Health and Disease
YouTube video by University of Washington Division of Nephrology
youtu.be
October 2, 2025 at 6:57 PM
Reposted by Gabriel Cara Fuentes
Progression of Coronary Artery Calcification and Risk of Clinical Events in CKD: The Chronic Renal Insufficiency Cohort Study

bit.ly/48yjx4v #OpenAccess
September 27, 2025 at 10:00 PM
Reposted by Gabriel Cara Fuentes
And it’s live

Iptacopan in C3GN makes it to @thelancet.com

www.thelancet.com/journals/lan...

#NephSky
September 26, 2025 at 9:37 AM
Reposted by Gabriel Cara Fuentes
Today is #C3GAwarenessDay! At ISGD, we stand with people living with this rare kidney disease. As a medical society for #GlomerularDisease experts, we're committed to raising awareness and moving the science forward to bring more hope and solutions to the C3G community. #C3G #ISGD
September 25, 2025 at 3:34 PM
Reposted by Gabriel Cara Fuentes
Clinical Endpoints for Glomerular Diseases from
@hjanders.bsky.social
#GlomConHawaii 🌊 #Nephpearls #NephSky
September 22, 2025 at 9:04 PM
Reposted by Gabriel Cara Fuentes
➡️ Randomized, Double-Blind, Placebo-Controlled Phase 2a Study Assessing the Efficacy and Safety of Felzartamab for IgA Nephropathy www.kidney-internati...
September 18, 2025 at 1:47 PM
Reposted by Gabriel Cara Fuentes
In Vivo CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus | New England Journal of Medicine www.nejm.org/doi/full/10....
In Vivo CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus | NEJM
In patients with refractory systemic lupus erythematosus, in vivo generation of CD19 CAR T cells by means of lipid nanoparticles led to B-cell depletion, reduced disease activity, and no major toxi...
www.nejm.org
September 18, 2025 at 12:40 AM
Reposted by Gabriel Cara Fuentes
Commentary
Distinguishing signal from noise: a new era of autoantibody testing in podocytopathies requires thoughtful approaches
Ghasemi M and Weins A

doi.org/10.1016/j.kint.2025.05.026

Original article: doi.org/10.1016/j.kint.2025.02.028

#MedSky #NephSky #FSGS #IgG #IgM #minimalchangedisease
September 4, 2025 at 6:37 PM
Reposted by Gabriel Cara Fuentes
🚨 Attention Mount Sinai Postdocs! 🚨
THIS WEEK is your final opportunity to apply for the Kiiln Innovation Award! 🎉
Submit your application by this Friday!
We want to support your innovative journeys. Let’s push the boundaries together! 💡 @spocuaw.bsky.social @mountsinainyc.bsky.social
📣 Exciting news! KiiLN cofounders are thrilled to continue our support for innovative postdocs for another year! 🌟 If you're an @iSMMS postdoc with groundbreaking ideas, don't miss out—apply now! 🚀 @spocuaw.bsky.social @mountsinainyc.bsky.social #PostdocOpportunities #Innovation
September 3, 2025 at 5:00 PM